DAX23.609 -0,1%Est505.765 -0,5%MSCI World4.343 -0,1%Top 10 Crypto9,1700 -1,6%Nas22.716 +0,1%Bitcoin60.452 -0,6%Euro1,1559 ±0,0%Öl97,21 +3,8%Gold5.184 +0,5%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 BioNTech (ADRs) A2PSR2 Lufthansa 823212 SAP 716460 NVIDIA 918422 Siemens Energy ENER6Y DroneShield A2DMAA Bayer BAY001 Volkswagen (VW) vz. 766403 Allianz 840400 Deutsche Telekom 555750 RENK RENK73 Vonovia A1ML7J Novo Nordisk A3EU6F Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Ölpreise steigen: DAX schwächer -- Verluste in Asien -- RWE besser als befürchtet -- Zalando: Aktienrückkauf -- BMW: Schwache Zahlen -- Daimler Truck, Siemens Energy, Rüstungsaktien, AIXTRON im Fokus
Top News
Analyse: So bewertet Warburg Research die Rheinmetall-Aktie Analyse: So bewertet Warburg Research die Rheinmetall-Aktie
Barclays Capital: Hannover Rück-Aktie erhält Underweight Barclays Capital: Hannover Rück-Aktie erhält Underweight
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

TransMedics Group Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
110,80 EUR -0,20 EUR -0,18 %
STU
127,80 USD -3,12 USD -2,38 %
nachbörslich
BTT
finanzen.net zero
TransMedics Group jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.3,83 Mrd. EUR

KGV24,96Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PH5P

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS89377M1099

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTMDX

TransMedics Group Aktien News

DatumMeistgelesen
PR NewswireTransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
PR NewswireTransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Wer­bungTransMedics Group-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireTransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Third Quarter 2025 Financial Results
PR NewswireTransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025
PR NewswireTransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy
PR NewswireTransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy
PR NewswireTransMedics to Present at Upcoming September Investor Conferences
PR NewswireTransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics Reports Second Quarter 2025 Financial Results
PR NewswireTransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference
PR NewswireTransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireTransMedics to Present at Upcoming June Investor Conferences
PR NewswireTransMedics Reports First Quarter 2025 Financial Results
PR NewswireTransMedics to Report First Quarter 2025 Financial Results on May 8, 2025
PR NewswireTMDX Deadline: TMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - TMDX
PR NewswireTMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireTransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDX
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
PR NewswireShareholders that lost money on TransMedics Group, Inc.(TMDX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
PR NewswireTMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR NewswireLost Money on TransMedics Group, Inc.(TMDX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
PR NewswireNASDAQ: TMDX INVESTOR ALERT: Berger Montague Advises TransMedics Group Investors of an April 15, 2025 Deadline
PR NewswireTMDX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireTransMedics Reports Fourth Quarter and Full Year 2024 Financial Results
PR NewswireTMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR NewswireTRANSMEDICS INVESTOR ALERT: TransMedics Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TMDX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TransMedics Group, Inc of Class Action Lawsuit and Upcoming Deadlines - TMDX
PR NewswireTransMedics to Present at Upcoming March Investor Conferences
PR NewswireTMDX Investors Have Opportunity to Lead TransMedics Group, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR NewswireTransMedics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
PR NewswireRosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX
PR NewswireTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

TransMedics Group News

TransMedics Group News: auf dieser Seite finden Sie alle TransMedics Group News und Nachrichten zur TransMedics Group Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch TransMedics Group News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um TransMedics Group News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.